The Experts below are selected from a list of 3816 Experts worldwide ranked by ideXlab platform
Heidi M Connolly - One of the best experts on this subject based on the ideXlab platform.
-
abstract 20034 fate of the native pulmonary Valve in patients with carcinoid heart disease after Tricuspid Valve Replacement
Circulation, 2016Co-Authors: Sushil Allen Luis, Hartzell V Schaff, Patricia A Pellikka, Heidi M ConnollyAbstract:Background: Carcinoid heart disease most frequently affects the right sided Valves. In carcinoid patients undergoing Tricuspid Valve Replacement, uncertainty exists regarding the surgical management of pulmonary Valve disease in the absence of severe pulmonary Valve dysfunction. We aimed to determine the long-term fate of the native pulmonary Valve after Tricuspid Valve Replacement (TVR) for carcinoid heart disease. Methods and results: A retrospective review of 222 surgical patients, operated at our institution between 1985 - 2015, identified 34 patients who underwent TVR without pulmonary Valve intervention. After exclusion of 17 patients with Conclusions: Although rare, Tricuspid carcinoid Valve disease without pulmonary Valve involvement at cardiac surgery was associated with a low risk of subsequent pulmonary Valve dysfunction and need for subsequent surgical intervention. Hence, it is reasonable to perform TVR without concomitant pulmonary Valve intervention, when preoperative testing demonstrates moderate or less PR.
-
abstract 20034 fate of the native pulmonary Valve in patients with carcinoid heart disease after Tricuspid Valve Replacement
Circulation, 2016Co-Authors: Sushil Allen Luis, Hartzell V Schaff, Patricia A Pellikka, Heidi M ConnollyAbstract:Background: Carcinoid heart disease most frequently affects the right sided Valves. In carcinoid patients undergoing Tricuspid Valve Replacement, uncertainty exists regarding the surgical managemen...
Kazutomo Minami - One of the best experts on this subject based on the ideXlab platform.
-
First case report in Japan of left ventricular pacing via a coronary vein in a patient with a mechanical Tricuspid Valve.
Circulation, 2008Co-Authors: Masataka Yoda, Toshiko Nakai, Kimie Okubo, Mitsumasa Hata, Akira Sezai, Atsushi Hirayama, Kazutomo MinamiAbstract:Transvenous endocardial pacemaker implantation is contraindicated in patients after prosthetic Tricuspid Valve Replacement. A 65-year-old woman underwent both Replacement of the mitral and Tricuspid Valves and pacemaker implantation with epicardial lead for bradycardia with chronic atrial fibrillation. At 2 years after this operation, the pacemaker's battery became low, and she was admitted for a battery exchange. To avoid frequent battery exchanges because of high stimulation thresholds, a left ventricular pacing lead was implanted via a coronary vein. There were no complications and the stimulation thresholds were stable. Coronary vein leads enable a minimally invasive approach, improve safety, and give effective stimulation for patients with a prosthetic Tricuspid Valve. This is the first case report in Japan of left ventricular pacing in such a patient. (Circ J 2008; 72: 335 - 336)
-
implantation of systems for cardiac resynchronisation tips and tricks cardiac surgeon s view
European Heart Journal Supplements, 2004Co-Authors: Bert Hansky, Kazutomo Minami, S Schulteeistrup, Juergen Vogt, Holger Gueldner, Dieter Horstkotte, Reiner KorferAbstract:Specific problems of cardiosurgical implantation of biventricular devices for cardiac resynchronisation therapy are elucidated elaborately. In particular, the necessity and amount of intraoperative monitoring as well as the appropriate mode of anaesthesia are described. Furthermore, the sequence of lead placement, the technique of coronary sinus intubation using a guiding catheter as well as means to avoid thrombus formation in the coronary sinus are depicted. Biventricular ICD devices should be implanted from a left sided approach to integrate the device into the defibrillation field and to maintain the option of placing an additional subcutaneous array lead. It is of particular cardiosurgical interest that coronary vein leads are applicable for ventricular stimulation in patients after Tricuspid Valve Replacement thus avoiding repeated surgical exposure of the heart.
-
coronary vein leads for cardiac pacing in patients with Tricuspid Valve Replacement
Thoracic and Cardiovascular Surgeon, 2002Co-Authors: Bert Hansky, Kazutomo Minami, Dieter Horstkotte, Holger Guldner, J Vogt, Gero Tenderich, Reiner KorferAbstract:BACKGROUND Because after Tricuspid Valve Replacement (TVR) the transvenous implantation of endocardial leads is contraindicated, myocardial screw-in leads were used to ventricular pacing. Recently available coronary vein (CV) leads are stimulating the left ventricle epicardially and can be implanted transvenously, too. METHOD AND RESULTS We implanted these leads in patients (pts) with TVR (n = 7) or after Valve repair (n = 1) without complications. In 7 pts we used bended CV leads with a microporous tip and only in one pt a CV lead with a stimulation via metal ring. The stimulation thresholds (ST) were stable in all pts. CONCLUSIONS The use of CV leads offers a minimal invasive approach for permanent cardiac stimulation after TVR. Low chronic ST are resulting in an energy saving pacemaker mode. CV leads can be used after previous heart surgery as well as for difficult anatomical situations.
David S Celermajer - One of the best experts on this subject based on the ideXlab platform.
-
percutaneous Tricuspid Valve Replacement for a stenosed bioprosthesis
Circulation-cardiovascular Interventions, 2010Co-Authors: Philip Roberts, Roberto Spina, Michael P Vallely, Michael K Wilson, Brian P Bailey, David S CelermajerAbstract:Percutaneous Replacement of the aortic and pulmonic Valves has rapidly gained acceptance in clinical practice as a feasible alternative to open Valve surgery in patients deemed to be at high operative risk.1,2 Total percutaneous Tricuspid Valve Replacement (TVR), on the other hand, has not yet been documented in humans, although this approach has been described in experimental animals.3 Webb et al4 have recently reported 1 case of TVR, using a Valve designed for percutaneous use but inserted through a thoracotomy with direct puncture of the right atrium. We describe a …
Hartzell V Schaff - One of the best experts on this subject based on the ideXlab platform.
-
abstract 20034 fate of the native pulmonary Valve in patients with carcinoid heart disease after Tricuspid Valve Replacement
Circulation, 2016Co-Authors: Sushil Allen Luis, Hartzell V Schaff, Patricia A Pellikka, Heidi M ConnollyAbstract:Background: Carcinoid heart disease most frequently affects the right sided Valves. In carcinoid patients undergoing Tricuspid Valve Replacement, uncertainty exists regarding the surgical management of pulmonary Valve disease in the absence of severe pulmonary Valve dysfunction. We aimed to determine the long-term fate of the native pulmonary Valve after Tricuspid Valve Replacement (TVR) for carcinoid heart disease. Methods and results: A retrospective review of 222 surgical patients, operated at our institution between 1985 - 2015, identified 34 patients who underwent TVR without pulmonary Valve intervention. After exclusion of 17 patients with Conclusions: Although rare, Tricuspid carcinoid Valve disease without pulmonary Valve involvement at cardiac surgery was associated with a low risk of subsequent pulmonary Valve dysfunction and need for subsequent surgical intervention. Hence, it is reasonable to perform TVR without concomitant pulmonary Valve intervention, when preoperative testing demonstrates moderate or less PR.
-
abstract 20034 fate of the native pulmonary Valve in patients with carcinoid heart disease after Tricuspid Valve Replacement
Circulation, 2016Co-Authors: Sushil Allen Luis, Hartzell V Schaff, Patricia A Pellikka, Heidi M ConnollyAbstract:Background: Carcinoid heart disease most frequently affects the right sided Valves. In carcinoid patients undergoing Tricuspid Valve Replacement, uncertainty exists regarding the surgical managemen...
-
preoperative factors associated with adverse outcome after Tricuspid Valve Replacement
Circulation, 2011Co-Authors: Yan Topilsky, Hartzell V Schaff, Amber Khanna, Rick A Nishimura, Maurice Enriquezsarano, Yang B Jeon, Thoralf M Sundt, Soon J ParkAbstract:Background—Preoperative factors associated with increased mortality and worse outcome after Tricuspid Valve Replacement in patients with severe Tricuspid regurgitation are poorly understood. Methods and Results—We retrospectively analyzed 189 patients (37% men; age, 67.5±11.3 years) who underwent Tricuspid Valve Replacement for severe Tricuspid regurgitation. Operative mortality rate was 10%, and was associated with intra-aortic balloon pump (odds ratio, 3.2; 95% confidence interval, 1.9 to 5.6; P<0.0001) or the presence of severe symptoms (New York Heart Association class IV relative to classes II and/or III) at the time of surgery (1.7; 95% confidence interval, 1.05 to 2.8; P=0.02). At the end of follow-up (29.3±27.1 months), 70 patients (37%) died, 6 (3%) needed Tricuspid reoperation, and 41 (21.7%) were readmitted for heart failure. Seventy-eight patients (41.3%) were free from cardiovascular events (death, Tricuspid reoperation, or heart failure admissions). The only echocardiographic parameter indep...
Sushil Allen Luis - One of the best experts on this subject based on the ideXlab platform.
-
abstract 20034 fate of the native pulmonary Valve in patients with carcinoid heart disease after Tricuspid Valve Replacement
Circulation, 2016Co-Authors: Sushil Allen Luis, Hartzell V Schaff, Patricia A Pellikka, Heidi M ConnollyAbstract:Background: Carcinoid heart disease most frequently affects the right sided Valves. In carcinoid patients undergoing Tricuspid Valve Replacement, uncertainty exists regarding the surgical management of pulmonary Valve disease in the absence of severe pulmonary Valve dysfunction. We aimed to determine the long-term fate of the native pulmonary Valve after Tricuspid Valve Replacement (TVR) for carcinoid heart disease. Methods and results: A retrospective review of 222 surgical patients, operated at our institution between 1985 - 2015, identified 34 patients who underwent TVR without pulmonary Valve intervention. After exclusion of 17 patients with Conclusions: Although rare, Tricuspid carcinoid Valve disease without pulmonary Valve involvement at cardiac surgery was associated with a low risk of subsequent pulmonary Valve dysfunction and need for subsequent surgical intervention. Hence, it is reasonable to perform TVR without concomitant pulmonary Valve intervention, when preoperative testing demonstrates moderate or less PR.
-
abstract 20034 fate of the native pulmonary Valve in patients with carcinoid heart disease after Tricuspid Valve Replacement
Circulation, 2016Co-Authors: Sushil Allen Luis, Hartzell V Schaff, Patricia A Pellikka, Heidi M ConnollyAbstract:Background: Carcinoid heart disease most frequently affects the right sided Valves. In carcinoid patients undergoing Tricuspid Valve Replacement, uncertainty exists regarding the surgical managemen...
